COMMUNIQUÉS West-GlobeNewswire

H1 Acquires Defacto Health to Strengthen Provider Network Intelligence
09/09/2026
Acquisition brings provider-network data and experienced healthcare data leaders to H1 NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- H1 , the AI-powered platform that connects the world to the right doctors, today [...]
Traver Strategic Holdings Acquires Apprio and Launches Varetis, Inc.
09/09/2026
ATLANTA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Traver Strategic Holdings LLC today announced its acquisition of Apprio, Inc., and the launch of Varetis, Inc., which will build on Apprio’s decades of federal experience [...]
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
09/09/2026
CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the grant of an [...]
ImPact Biotech Announces Completion of Treatment in Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC and Positive Regulatory Updates
09/09/2026
– Successful t reatment of 91 patients with consistent safety and efficacy results observed to date ; interim data to be presented at ESMO Congress in October 2026 – – W ritten feedback from FDA following pre-NDA [...]
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
09/09/2026
Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centers ATLANTA, Sept. 09, 2026 (GLOBE NEWSWIRE) -- [...]
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
09/09/2026
Grand Cayman, Cayman Islands, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) [...]
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
09/09/2026
Management to Highlight Growing Commercial Momentum of Arbli ™ and the Commercial Launch of REZENOPY ™ COMMACK, NY, Sept. 09, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding [...]
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
09/09/2026
Submission package includes Method Comparison Study, which delivered accuracy above 98%, sensitivity above 94%, and 100% specificity across three independent U.S. clinical sites NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE [...]
Syncromune® Presents SYNC-T™ Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026
09/09/2026
Invited speaker, Stephen Kee, M.D. reviews SYNC-T™ Therapy SV-102 mechanism, previously reported Phase 1 findings and ongoing Phase 2 LEGION-100 trial in metastatic prostate cancer FORT LAUDERDALE, Fla. and WEST DES [...]
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
09/09/2026
Public event brings together a radiologist, urologist and robotic surgeon, and a prostate cancer survivor for an informative conversation and live Q&A about prostate cancer screening, diagnosis and treatment LOS [...]
RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
09/09/2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Allogenetics Raises €3.8 Million Pre-Series A to Advance Novel Ex Vivo Gene Therapy Approach to Improve Organ Transplantation Outcomes
09/09/2026
Financing will support lead program ALG-115 through IND-enabling studies toward clinical evaluation in lung transplantation Round was led by NBank Capital with participation from CARMA FUND, Life Science Valley [...]
Athernal Bio Secures Innovate UK Grant to Advance Cancer Interception in High-Risk Leukaemia
09/09/2026
Innovate UK grant supports Athernal’s mission to intercept high-risk leukaemia before cancer develops Funding reflects growing confidence in cancer interception as an emerging therapeutic approach London, UK, September [...]
Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers
09/09/2026
Basel, Switzerland and Chassieu, France, , Sept. 09, 2026 (GLOBE NEWSWIRE) -- The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first [...]
Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide
09/09/2026
Bâle (Suisse) et Chassieu (France) , 09 sept. 2026 (GLOBE NEWSWIRE) -- Syngenta et Amoéba ont conclu un accord de distribution exclusif en Europe pour proposer aux céréaliers une innovation biofongicide Cet accord [...]
Oral Infigratinib Shows Meaningful Benefits Beyond Growth Within 52 Weeks in Children with Achondroplasia in the Phase 3 PROPEL 3 Trial
09/09/2026
- Treatment with oral infigratinib for 52 weeks in PROPEL 3 resulted in favorable trends against placebo in clinically meaningful exploratory endpoints including sleep apnea and otitis media events Stabilization of [...]
ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury
09/09/2026
Investment supports application of ViaNautis’ polyNaut ® platform to regenerative therapies for spinal cord injury, where targeted delivery remains a huge barrier Adds a new high-value CNS indication and provides [...]
Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026
09/09/2026
Industry symposium to explore local delivery of combination antibiotics across spine and arthroplasty Poster showcases the efficacy of STIMULAN ® calcium sulfate beads, loaded with a combination of Gram-positive and [...]
Allegro’s Hydrocelin significantly improves knee osteoarthritis pain and function in clinical trial
09/09/2026
Nanotechnology-based injection significantly improved knee pain and function with favorable safety and efficacy sustained over 6 months following a single administration Feasibility trial in Belgium completed [...]

Pages